Anna Möllsten

1.6k total citations
26 papers, 779 citations indexed

About

Anna Möllsten is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Anna Möllsten has authored 26 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Genetics and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Anna Möllsten's work include Diabetes Management and Research (12 papers), Diabetes and associated disorders (9 papers) and Diabetes Treatment and Management (6 papers). Anna Möllsten is often cited by papers focused on Diabetes Management and Research (12 papers), Diabetes and associated disorders (9 papers) and Diabetes Treatment and Management (6 papers). Anna Möllsten collaborates with scholars based in Sweden, Denmark and Finland. Anna Möllsten's co-authors include Gisela Dahlquist, Ingeborg Waernbaum, Torbjörn Lind, Kerstin Brismar, Maria Svensson, Susanne Rudberg, Lise Tarnow, Eva‐Lena Stattin, Anders Jorsal and Maria Lajer and has published in prestigious journals such as Diabetes Care, Diabetes and Diabetologia.

In The Last Decade

Anna Möllsten

26 papers receiving 763 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Möllsten Sweden 15 376 275 193 134 120 26 779
Marianne Henricsson Sweden 16 564 1.5× 296 1.1× 355 1.8× 195 1.5× 89 0.7× 19 1.2k
Ching-Chu Chen Taiwan 17 415 1.1× 243 0.9× 143 0.7× 328 2.4× 144 1.2× 29 1.1k
Jun‐Sing Wang Taiwan 17 411 1.1× 103 0.4× 152 0.8× 226 1.7× 159 1.3× 93 1.0k
Shuli He China 13 154 0.4× 77 0.3× 155 0.8× 154 1.1× 66 0.6× 32 685
A. Corgnati Italy 13 362 1.0× 103 0.4× 180 0.9× 189 1.4× 126 1.1× 23 899
K. Py�r�l� Finland 9 456 1.2× 84 0.3× 157 0.8× 115 0.9× 300 2.5× 13 774
Y Ohkubo Japan 4 529 1.4× 67 0.2× 107 0.6× 149 1.1× 124 1.0× 9 731
Ling Ge United States 11 483 1.3× 73 0.3× 110 0.6× 192 1.4× 190 1.6× 24 798
Fone‐Ching Hsiao Taiwan 18 256 0.7× 51 0.2× 161 0.8× 241 1.8× 133 1.1× 42 848
Grażyna Bednarek-Tupikowska Poland 15 275 0.7× 106 0.4× 107 0.6× 118 0.9× 123 1.0× 72 771

Countries citing papers authored by Anna Möllsten

Since Specialization
Citations

This map shows the geographic impact of Anna Möllsten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Möllsten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Möllsten more than expected).

Fields of papers citing papers by Anna Möllsten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Möllsten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Möllsten. The network helps show where Anna Möllsten may publish in the future.

Co-authorship network of co-authors of Anna Möllsten

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Möllsten. A scholar is included among the top collaborators of Anna Möllsten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Möllsten. Anna Möllsten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Waernbaum, Ingeborg, Torbjörn Lind, Anna Möllsten, & Gisela Dahlquist. (2022). The incidence of childhood-onset type 1 diabetes, time trends and association with the population composition in Sweden: a 40 year follow-up. Diabetologia. 66(2). 346–353. 9 indexed citations
2.
Persson, Emma, et al.. (2021). Risk of cancer in young and middle‐aged adults with childhood‐onset type 1 diabetes in Sweden—A prospective cohort study. Diabetic Medicine. 39(3). e14771–e14771. 3 indexed citations
3.
Möllsten, Anna, Ingeborg Waernbaum, Staffan Schön, et al.. (2018). Decreasing Cumulative Incidence of End-Stage Renal Disease in Young Patients With Type 1 Diabetes in Sweden: A 38-Year Prospective Nationwide Study. Diabetes Care. 42(1). 27–31. 22 indexed citations
4.
5.
Möllsten, Anna, et al.. (2013). Socioeconomic risk factors for developing end stage renal disease in patients with childhood onset type 1 diabetes : a population based register study. Diabetologia. 56. 1 indexed citations
6.
Möllsten, Anna, et al.. (2013). Renal replacement therapy due to type 1 diabetes; time trends during 1995–2010 – A Swedish population based register study. Journal of Diabetes and its Complications. 28(2). 152–155. 7 indexed citations
7.
Gu, Tianwei, Eva Horová, Anna Möllsten, et al.. (2012). IGF2BP2 and IGF2 genetic effects in diabetes and diabetic nephropathy. Journal of Diabetes and its Complications. 26(5). 393–398. 32 indexed citations
8.
9.
Möllsten, Anna, Nathalie Vionnet, Carol Forsblom, et al.. (2011). A polymorphism in the angiotensin II type 1 receptor gene has different effects on the risk of diabetic nephropathy in men and women. Molecular Genetics and Metabolism. 103(1). 66–70. 15 indexed citations
10.
Waernbaum, Ingeborg, et al.. (2011). Thirty Years of Prospective Nationwide Incidence of Childhood Type 1 Diabetes. Diabetes. 60(2). 577–581. 182 indexed citations
11.
Möllsten, Anna, Anders Jorsal, Maria Lajer, Nathalie Vionnet, & Lise Tarnow. (2009). The V16A polymorphism in SOD2 is associated with increased risk of diabetic nephropathy and cardiovascular disease in type 1 diabetes. Diabetologia. 52(12). 2590–2593. 41 indexed citations
12.
Dahlquist, G, et al.. (2008). Hospitalization for vascular complications in childhood onset type 1 diabetes – effects of gender and age at onset. Acta Paediatrica. 97(4). 483–488. 9 indexed citations
13.
Möllsten, Anna, Birgitta Stegmayr, & Per-Gunnar Wiklund. (2008). Genetic polymorphisms in the renin–angiotensin system confer increased risk of stroke independently of blood pressure: a nested case–control study. Journal of Hypertension. 26(7). 1367–1372. 31 indexed citations
14.
Möllsten, Anna, Ingrid Kockum, Maria Svensson, et al.. (2008). The effect of polymorphisms in the renin–angiotensin–aldosterone system on diabetic nephropathy risk. Journal of Diabetes and its Complications. 22(6). 377–383. 20 indexed citations
15.
Ma, Jun, Anna Möllsten, Henrik Falhammar, et al.. (2007). Distribution of neuropeptide Y Leu7Pro polymorphism in patients with type 1 diabetes and diabetic nephropathy among Swedish and American populations. European Journal of Endocrinology. 157(5). 641–645. 13 indexed citations
16.
Ma, Jun, Anna Möllsten, Henrik Falhammar, et al.. (2006). Genetic association analysis of the adiponectin polymorphisms in type 1 diabetes with and without diabetic nephropathy. Journal of Diabetes and its Complications. 21(1). 28–33. 23 indexed citations
17.
Möllsten, Anna, Maija Wessman, Maria Svensson, et al.. (2006). Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy. Annals of Medicine. 38(7). 522–528. 26 indexed citations
18.
Ma, Jun, Anna Möllsten, Martin Prázný, et al.. (2006). Genetic influences of the intercellular adhesion molecule 1 (ICAM‐1) gene polymorphisms in development of Type 1 diabetes and diabetic nephropathy. Diabetic Medicine. 23(10). 1093–1099. 43 indexed citations
19.
Möllsten, Anna, Stefan L. Marklund, Maija Wessman, et al.. (2006). A Functional Polymorphism in the Manganese Superoxide Dismutase Gene and Diabetic Nephropathy. Diabetes. 56(1). 265–269. 85 indexed citations
20.
Möllsten, Anna, Gisela Dahlquist, Eva‐Lena Stattin, & Susanne Rudberg. (2001). Higher Intakes of Fish Protein Are Related to a Lower Risk of Microalbuminuria in Young Swedish Type 1 Diabetic Patients. Diabetes Care. 24(5). 805–810. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marianne Henricsson Breakdown of academic impact, for papers by Ching-Chu Chen Breakdown of academic impact, for papers by Jun‐Sing Wang Breakdown of academic impact, for papers by Shuli He Breakdown of academic impact, for papers by A. Corgnati Breakdown of academic impact, for papers by K. Py�r�l� Breakdown of academic impact, for papers by Y Ohkubo Breakdown of academic impact, for papers by Ling Ge Breakdown of academic impact, for papers by Fone‐Ching Hsiao Breakdown of academic impact, for papers by Grażyna Bednarek-Tupikowska
Rankless by CCL
2026